Patents (1436 Stem Cell Patents)

Class: Type (195)

Order by:
<< | < | 4 5 6 7 8 9 10 11 12 | > | >>


Stem cells bearing an FGF receptor on the cell surface

Patent Number: 6767737

This patent is on a type of stem cell that expresses the fibroblast growth factor receptor. This is a composition of matter patent on a stem cell and could be very useful for strategic positioning of companies in the area of stem cell therapeutics.

Inventors: Wilson, E. Lynette (New York, NY); Burger, Patricia E. (Cape Town, ZA)
Assignee: New York University (New York, NY)
Date of First Priority Issue: Monday August 31st, 1998

Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders

Patent Number: 6517833

This patent teaches the use of pig retinal cells and a variety of stem cells associated with retinal development, as a source of cellular material for transplantation into humans that suffer from various ocular diseases.

Inventor: Edge, Albert (Cambridge, MA)
Assignee: Diacrin, Inc. (Charlestown, MA)
Date of First Priority Issue: Tuesday August 25th, 1998

Engraftable human neural stem cells

Patent Number: 6680198

This patent teaches a type of neuronal stem cell that can be used for cell therapy of neurological disorders. Characterization of the cell is provided and includes expression of EGF and FGF receptors.

Inventors: Snyder, Evan Y. (Jamaica Plain, MA); Wolfe, John H. (Philadelphia, PA); Kim, Seung U. (Vancouver, CA)
Assignee: The Children's Medical Center Corporation (Boston, MA); University of British Columbia (Vancouver, GB); University of Pennsylvania (Philadelphia, PA)
Date of First Priority Issue: Friday August 14th, 1998

Engraftable human neural stem cells

Patent Number: 6541255

These are stem cells that are isolated from human fetal telencephalon and are useful for engrafting and generating various neuronal structures.

Inventors: Snyder, Evan Y. (Jamaica Plain, MA); Wolfe, John H. (Philadelphia, PA); Kim, Seung U. (Vancouver, CA)
Assignee: The Children's Medical Center Corporation (Boston, MA); The University of British Columbia (CA); The University of Pennsylvania (Philadelphia, PA)
Date of First Priority Issue: Friday August 14th, 1998

Engraftable human neural stem cells

Patent Number: 5958767

This patent covers a type of neural stem cells that is isolated from human fetal telencephalon. This stem cell can be propagated in vitro and subsequently implanted for therapeutic benefit in a wide variety of animal models.

Inventors: Snyder, Evan Y. (Jamaica Plain, MA); Wolfe, John H. (Philadelphia, PA); Kim, Seung U. (Vancouver, CA)
Assignee: The Children's Medical Center Corp. (Boston, MA)
Date of First Priority Issue: Friday August 14th, 1998

Genetically modified CD34-negative adherently growing stem cells and their use in gene therapy

Patent Number: 6361997

This patent provides stem cells that are mesenchymal-like or lack expression of CD34, for the purpose of transfection with a foreign gene.

Inventor: Huss, Ralf (83666 Waakirchen, DE)
Assignee: Unknown Assignee(s)
Date of First Priority Issue: Friday July 24th, 1998

Liver stem cell

Patent Number: 6872389

This patent covers a liver stem cell that is isolated based on expression of the marker OV6. These cells could be used for a variety of therapeutic purposes including hepatitis. Liver cell therapy can be performed by administration of single cell suspensions, additionally attractive with this patent is that liver cells are generally more tolerogenic and less likely...

Inventor: Faris, Ronald A. (Providence, RI)
Assignee: Rhode Island Hospital (Providence, RI)
Date of First Priority Issue: Friday July 10th, 1998

Liver stem cell

Patent Number: 6129911

This patent covers the stem cell for livers. Given the strong regenerative capacity of the liver, the characterization of stem cells of this organ is of great interest. Specific markers and methods of expanding liver stem cells are provided. The patent is currently owned by a company called MultiCell.

Inventor: Faris, Ronald A. (Providence, RI)
Assignee: Rhode Island Hospital, A LifeSpan Partner (Providence, RI)
Date of First Priority Issue: Friday July 10th, 1998

Compositions and methods for use in affecting hematopoietic stem cell populations in mammals

Patent Number: 6586192

This patent seems to cover a type of hematopoietic stem cell that is positive for expression of the marker KDR-1.

Inventors: Peschle, Cesare (Rome, IT); Ziegler, Benedikt L. (Tuebingen, DE)
Assignee: Thomas Jefferson University (Philadelphia, PA); Instituto Superiore di Sanita (Rome, IT)
Date of First Priority Issue: Friday May 29th, 1998

Human mesenchymal stem cells

Patent Number: 6387367

This patent covers mesenchymal stem cells and provides a specific phenotype for them which includes CD45+, SH2,3,4+, and in some cases CD14+. This patent is important for anyone operating in the area of mesenchymal stem cells since it essentially covers the use of this specific cell population. Patents on...

Inventors: Davis-Sproul, Janice M. (Towson, MD); Moorman, Mark Aaron (Baltimore, MD); McNeil, Renee Marie (Baltimore, MD); Simonetti, Jr., Donald William (Forest Hill, MD); Hammill, Lora Catherine (Bel Air, MD); Craig, Stewart (Timonium, MD)
Assignee: Osiris Therapeutics, Inc. (Baltimore, MD)
Date of First Priority Issue: Friday May 29th, 1998

Order by:
<< | < | 4 5 6 7 8 9 10 11 12 | > | >>

Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent